A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.

about

A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.

Item

http://www.wikidata.org/entity/Q42697087

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@en

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@nl

type

Item

label

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@en

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@nl

prefLabel

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@en

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@nl

P1476

A 6-Month Open-Label Extension ...... pressive or Anxiety Disorders.

@en

P2093

Adelaide S Robb

http://www.w3.org/2001/XMLSchema#string

Elias H Sarkis

http://www.w3.org/2001/XMLSchema#string

Grace Chen

http://www.w3.org/2001/XMLSchema#string

Lis H Poulsen

http://www.w3.org/2001/XMLSchema#string

Melissa P DelBello

http://www.w3.org/2001/XMLSchema#string

Michael Huss

http://www.w3.org/2001/XMLSchema#string

Nora K McNamara

http://www.w3.org/2001/XMLSchema#string

Ole M Lemming

http://www.w3.org/2001/XMLSchema#string

Philippe Auby

http://www.w3.org/2001/XMLSchema#string

Robert L Findling

http://www.w3.org/2001/XMLSchema#string

P2860

Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine

Q28290952

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.

Has adolescent suicidality decreased in the United States? Data from two national samples of adolescents interviewed in 1995 and 2005.

Epidemiology of mental disorders in children and adolescents.

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults.

Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.

The association between major depressive disorder in childhood and risk factors for cardiovascular disease in adolescence.

P304

47-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CAP.2017.0047

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29035574

http://www.w3.org/2001/XMLSchema#string

P932

5771527

http://www.w3.org/2001/XMLSchema#string